Valuation: Treace Medical Concepts, Inc.

Capitalization 175M 150M 141M 131M 242M 15.71B 263M 1.64B 635M 7.42B 655M 641M 27.13B P/E ratio 2025 *
-2.92x
P/E ratio 2026 * -3.24x
Enterprise value 172M 148M 138M 129M 238M 15.47B 259M 1.62B 625M 7.31B 645M 631M 26.71B EV / Sales 2025 *
0.81x
EV / Sales 2026 * 0.88x
Free-Float
75.16%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 week-8.05%
Current month-8.05%
1 month-56.02%
3 months-61.79%
6 months-52.84%
Current year-63.17%
More quotes
1 week 2.63
Extreme 2.63
3.03
1 month 2.56
Extreme 2.5559
4.81
Current year 2.56
Extreme 2.5559
10.79
1 year 2.56
Extreme 2.5559
10.79
3 years 2.56
Extreme 2.5559
27.97
5 years 2.56
Extreme 2.5559
37.17
10 years 2.56
Extreme 2.5559
37.17
More quotes
Manager TitleAgeSince
Chief Executive Officer 53 2013-06-30
Director of Finance/CFO 55 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 53 2025-05-19
Director/Board Member 63 2020-11-19
Director/Board Member 67 2020-11-19
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
0.00%-8.05%-65.45%-88.53% 175M
-0.01%+0.01%+0.01%+43.87% 12.57B
+2.02%+2.55%+26.74%+39.19% 11.77B
-0.41%-0.53%-16.56%+2.19% 7.61B
+0.24%-1.72%+23.33%-11.22% 6.11B
-0.03%+4.60%+16.12%+23.83% 5.23B
-0.14%+1.23%+6.67%+2.64% 5.1B
-0.17%+3.12%-8.84%+74.99% 4.82B
+0.05%-.--%+56.56%+14.67% 4.7B
-1.00%-5.18%+54.01%-12.40% 2.01B
Average +0.06%-0.86%+9.26%+8.92% 6.01B
Weighted average by Cap. +0.31%+0.43%+12.82%+24.77%
See all sector performances

Financials

2025 *2026 *
Net sales 212M 182M 171M 159M 294M 19.07B 320M 2B 771M 9.01B 795M 778M 32.93B 214M 184M 173M 161M 297M 19.28B 323M 2.02B 779M 9.11B 804M 787M 33.29B
Net income -59.21M -50.9M -47.68M -44.44M -82.09M -5.33B -89.28M -558M -215M -2.52B -222M -217M -9.2B -54.24M -46.63M -43.68M -40.71M -75.2M -4.88B -81.79M -511M -197M -2.31B -204M -199M -8.43B
Net Debt -2.72M -2.34M -2.19M -2.04M -3.77M -245M -4.1M -25.62M -9.89M -116M -10.21M -9.99M -423M 13.98M 12.02M 11.26M 10.5M 19.39M 1.26B 21.09M 132M 50.86M 594M 52.49M 51.37M 2.17B
More financial data * Estimated data
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Employees
477
More about the company
Date Price Change Volume
25-12-05 2.740 $ 0.00% 613,791
25-12-04 2.740 $ +2.24% 733,622
25-12-03 2.680 $ -0.74% 682,693
25-12-02 2.700 $ -4.59% 591,710
25-12-01 2.830 $ -5.03% 738,113

Delayed Quote Nasdaq, December 05, 2025 at 04:00 pm EST

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
2.740USD
Average target price
5.470USD
Spread / Average Target
+99.64%
Consensus

Quarterly revenue - Rate of surprise